Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in CancerCarter J. Barger(University of California, San Francisco), Adam R. Karpf(University of Nebraska Medical Center)CancersFebruary 21, 201910.3390/cancers11020251Cited by 226SaveCiteExport RISWatch citationsRelated PapersNB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells|Journal of Ovarian Research|2024|10New 1,1-diarylethylene FOXM1 inhibitors potently reduce intracellular FOXM1 and suppress high-grade serous ovarian carcinoma cell viability|Research Square|2022|2